Anti-inflammatory function of PPARγ has been studied in multiple inflammatory diseases including rheumatoid arthritis, diabetes, inflammatory bowel disease and atherosclerosis in which PPARγ agonists such as rosi have been used57, 58, 59. This evidence concerns the gene PPARG and inflammatory bowel disease.